Fellowship Directors' Section Education & Training Committee - Financial Interest Disclosures

Disclosures

ASRS adheres to the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

The individuals below have responded that they have no relevant financial relationships with ineligible entities:

Planning Committee Members:

Gregory Blaha, MD

Christopher Conrady, MD, PhD

Ghassan Ghorayeb, MD

Michelle Liang, MD

Steven Ness, MD

Merina Thomas, MD

Sami Uwaydat, MD

Alexis Warren, MD

The individuals below have disclosed the following financial relationships with ineligible entities:

 Planning Committee Members: Name of Ineligible Company/Nature of Relationship

Mark Breazzano, MD, FACS, Iveric Bio_Astellas,Advisory Board, Iveric Bio_Astellas,Speaker Bureau, ONL Therapeutics, Consultant.

Vaidehi Dedania, MD, Abbvie, Advisory Board Member, Abbvie, Consultant, Alimera Sciences, Advisory Board Member, Character Bio, Consultant, Iveric Bio, Advisory Board Member, EyePoint, Advisory Board Member, ONL Therapeutics, Consultant, Spark Therapeutics, Consultant.

Mrinali Gupta, MD, Alcon, Consultant, Alimera, Advisory Board Member, Carl Zeiss, Advisory Board Member.

Talia Kaden, MD, Abbvie, Advisory Board Member, Alimera, Advisory Board Member, Genentech, Advisory Board Member, Regeneron, Advisory Board Member

Tianyu Liu, MD, Alimera Sciences, Consultant, EyePoint Pharmaceuticals, Consultant 

Alexander Melamud, MD, Iveric Bio, Advisory Board Member

John Miller, MD, Alcon, Consultant, Boehringer, Consultant, Sunovion, Consultant, Topcon, Consultant, Zeiss, Consultant. 

Bradley Smith, MD, Eyepoint Pharmaceuticals,  Advisory Board Member, REGENXBIO, Consultant

Yoshihiro Yonekawa, MD, Alcon, Consultant, Apellis, Consultant, Bausch-Health, Consultant,  Eyepoint, Consultant, Genentech, Principle or Named Investigator, Genentech, Consultant, Kodiak, Principle or Named Investigator, Kyowa-Kirin, Principle or Named Investigator, Ocugen, Principle or Named Investigator, Regeneron, Principle or Named Investigator, Versant Health, Advisory Board Member.